Sarah J. Lord, MBBS, MS; Les Irwig, MBBCh, PhD; R. John Simes, MBBS, MS, MD
Grant Support: The authors have received funding from the Australian Medical Services Advisory Committee for the development of guidelines for the assessment of diagnostic technologies and National Health and Medical Research Council Program Grants (253602, 402764)
Potential Financial Conflicts of Interest: None disclosed.
Requests for Single Reprints: Sarah J. Lord, MBBS, MS, National Health and Medical Research Council Clinical Trials Centre, University of Sydney, 88 Mallett Street, Camperdown NSW, 2050 Australia; e-mail, firstname.lastname@example.org.
Current Author Addresses: Drs. Lord and Simes: National Health and Medical Research Council Clinical Trials Centre, University of Sydney, 88 Mallett Street, Camperdown NSW, 2050 Australia.
Dr. Irwig: School of Public Health, A27, Edward Ford Building, University of Sydney, NSW 2006 Australia.
The clinical value of using a new diagnostic test depends on whether it improves patient outcomes beyond the outcomes achieved using an old diagnostic test. When can studies of diagnostic test accuracy provide sufficient information to infer clinical value, and when do clinicians need to wait for results from randomized trials? The authors argue that accuracy studies suffice if a new diagnostic test is safer or more specific than, but of similar sensitivity to, an old test. However, if a new test is more sensitive than an old test, it leads to the detection of extra cases of disease. Results from treatment trials that enrolled only patients detected by the old test may not apply to these extra cases. Clinicians need to wait for results from randomized trials assessing treatment efficacy in cases detected by the new diagnostic test, unless they can be satisfied that the new test detects the same spectrum and subtype of disease as the old test or that treatment response is similar across the spectrum of disease.
Sarah J. Lord, Les Irwig, R. John Simes. When Is Measuring Sensitivity and Specificity Sufficient To Evaluate a Diagnostic Test, and When Do We Need Randomized Trials?. Ann Intern Med. 2006;144:850–855. doi: 10.7326/0003-4819-144-11-200606060-00011
Download citation file:
Published: Ann Intern Med. 2006;144(11):850-855.
Breast Cancer, Cancer Screening/Prevention, Cardiology, Colonoscopy/Sigmoidoscopy, Colorectal Cancer.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use